HMT-3522 S1

Кат. номер

98102210-CDNA-20UL

98102210-1VL

98102210-DNA-5UG

98102210-RNA-5UG

Human Caucasian breast epithelial
HMT-3522 S1, also known as HMT-3522/wt, is a subline that has been derived from HMT-3522. The parent line was established from a benign breast tumour of a 48 year old woman and has undergone spontaneous malignant transformation. It was grown on collagen in serum-free media without antibiotics from explantation onwards. A mutation at codon 179 of the p53 gene was detected during establishment of the parent line. HMT-3522 S1 is a continuation of this line from passage 34 growing without collagen. Subline S2 (Sigma catalog no. 98102211) has been isolated by culturing S1 cells from passage 118 in serum-free media without epidermal growth factor (EGF). The third subline, T4-2 (Sigma catalog no. 98102212) was established from S2 at passage 238 and is the only tumorigenic line in nude mice out of the 3 sublines. S2 and T4-2 grow on collagen-coated flasks. HMT-3522 S1 is near-diploid, but an evolution of karyotype has been observed by regular chromosomal analyses. The expression of cytokeratin 13, 14, 17 and 18 and vimentin has been reported. Expression of EGF-R, c-erb-B2, N-myc, c-ras-Ha1, c-ras-Ki2 and N-ras was shown to fluctuate slightly with passage number. The cells have tested negative for estrogen receptor, c-erbA1, c-erb-A2, int-2 or hst-1. During propagation growth factor requirements decreased simultaneously with amplification and overexpression of c-myc protooncogene. In a three-dimensional basement membrane culture assay the phenotypic characteristics of normal breast tissue in vivo are recapitulated. This cell line has remained non-tumorigenic for more than 400 passages. Publications using this cell line must refer to the original paper. Any sublines created must include the name HMT-3522 in the designation, but a short name may be used in the same paper.
Not specified
DMEM / Ham′s F12 (1:1) + 2 mM Glutamine + 250 ng/ml insulin + 10 μg/ml transferrin +10E-8M sodium selenite + 10E-10M 17 beta-estradiol + 0.5 μg/ml hydrocortisone + 5 μg/ml ovine prolactin + 10 ng/ml EGF
If starting from a frozen ampoule the cryoprotectant should be removed. Add thawed cells to a conical based centrifuge tube e.g. 15 ml tube; slowly add 4 ml of culture medium to the tube. Take a sample of the cell suspension, e.g. 100 ul, to count cells. Centrifuge the cell suspension at low speed, i.e., 100-150 x g for a maximum of 5 minutes.Split subconfluent cultures using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37 °C. Seed pre-coated flasks at 2-4 x 10, 000 cells/cm2. Cells detach slowly; add same volume of trypsin inhibitor as trypsin used, centrifuge and reseed cells in collagen IV coated flasks. Medium is serum-free, therefore trypsin inhibitor is essential. S1cells can be slow in spreading out after subculture and may take 2-3 days to attach. Good growth occurs 5-7 days after subculture.
Cells should be frozen in (45% conditioned media: 45% fresh media) with 10% DMSO.
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

biological source	human breast
growth mode	Adherent
karyotype	45,XX,1p-,-6,8q+-,12p+,14q+,17q+
morphology	Epithelial-like
products	Not specified
receptors	EGF
application(s)	cell culture | mammalian: suitable
relevant disease(s)	cancer
shipped in	dry ice
storage temp.	−196°C

RIDADR

NONH for all modes of transport